Dr. Ameli Tropé, MD, Specialist in Obstetrics and Gynaecology, holds a PhD in “Testing for Human Papillomavirus and Cervical Neoplasia”. Committed to rejuvenating Norwegian colposcopy, she completed training and the Observed Structured Clinical Exam (OSCE) in England, focusing on cervical and vulvar dysplasia. Dr Tropé leads the Norwegian Cervical Cancer Screening Programme, spearheading initiatives such as HPV primary screening and HPV self-sampling implementation. Dedicated to enhancing every aspect of cervical cancer screening, since 2015, Dr Tropé has orchestrated social media campaigns to boost screening attendance and quality. She also oversees smear-taking and quality assurance in pathology and microbiology labs. Dr Tropé organises annual colposcopy hands-on courses, assembling experts to train Norwegian gynaecologists.

 

* Thursday 19th of September 2024, Chair of Communication with patients and social media, from 16:30 to 17:30.  

Dr. Amelia Pedro serves as the Coordinator of the Cervix, Vagina, and Vulva Unit, as well as the Head of the Gynaecology and Obstetrics Department and Clinical Director at CUF Sintra Hospital. She holds the esteemed position of President at the Portuguese Society of Colposcopy and Pathology of the Lower Genital Tract (SPCPTGI), demonstrating her leadership and expertise in the field. Furthermore, Amelia Pedro chairs the Education Committee of the European Federation for Colposcopy (EFC), contributing significantly to advancing knowledge and practices in the field of colposcopy. She is accredited in Colposcopy by both the SPCPTGI and the Spanish Association of Cervical Pathology and Colposcopy (AEPCC), reflecting her commitment to maintaining high standards of care and professionalism. Amelia Pedro is also a distinguished Graduate Assistant/Consultant in Gynaecology and Obstetrics, showcasing her extensive experience and dedication to women’s health.

 

* Wednesday 18th of September 2024, Chair of the Basic colposcopy course, Speaker of Colposcopic principles, from 09:00 to 10:30.

* Thursday 19th of September 2024, HPV vaccination: moving towards cervical cancer eradication, Speaker of Vaccination after treatment of SIL? , from 15:10 to 15:35. 

Dr. Andrea Ciavattini, Full Professor in Gynaecology and Obstetrics at the Department of Odontostomatologic and Specialized Clinical Sciences, Medicine and Surgery, Università Politecnica delle Marche, Italy, brings extensive expertise to the field. As Chief of Obstetrics and Gynaecology Clinical at the Maternal and Child Department of Marche University Hospital, he spearheads advancements in maternal and child health care. Dr Ciavattini serves as President of the Italian Society for Colposcopy and Cervico-Vaginal Pathology, shaping the landscape of colposcopy and cervical pathology in Italy. Moreover, he is a Member of the Executive Board of the International Federation of Cervical Pathology and Colposcopy, and a Member of the European Federation for Colposcopy Quality and Standards Group. With a Second Level Master’s Degree in “Operative Management of Pathology of the Lower Genital Tract and Endometrial Cavity” from Università Politecnica delle Marche, Dr Ciavattini exemplifies dedication to advancing clinical care and education in his field.

 

* Wednesday 18th of September 2024, Workshop – Difficult cases in colposcopy, Speaker of Pregnancy cases, from 09:00 to 10.30.

* Friday 20th of September 2024, Optimal management of cervical intraepithelial lesions, Speaker of Management of persistent HPV and low-grade lesions, from 09:00 to 09:15.

Dr. Anne Hammer, Consultant and Head of Research at the Department of Obstetrics and Gynaecology, Gødstrup Hospital, also holds the position of Associate Professor of Obstetrics and Gynaecology at Aarhus University. With a rich academic background, she has served as a visiting scholar at the HPV Prevention Center, University of New Mexico, Albuquerque, USA, and as a research fellow at the Department of Global Health, George Washington University, Washington DC, USA, and the National Cancer Institute, USA. Her primary research focuses on cervical cancer prevention, epidemiology, and translational research. Currently supervising 4 PhD students, she actively participates in numerous national and international projects, demonstrating her dedication to advancing women’s health on a global scale.

 

* Thursday 19th of September 2024, Chair of Current knowledge on HPV natural history from 09:15 to 10:45 and  Speaker of Clinical implications of HPV latency, from 09:30 to 09:45.

* Thursday 19th of September 2024, Working towards eliminating cervical cancer: current knowledge on HPV natural history and screening: part II Speaker of Screening for cervical cancer in older women, from 11:45 to 11:55. 

* Friday 20th of September 2024, Chair of Selected best oral presentations,  from 08:30 to 09:00.

* Friday 20th of September 2024, Ensuring standards and quality assurance in women in Europe: colposcopy standards, Speaker of Feasibility of collecting and comparing quality indicators on colposcopy: an update from the EFC Quality and standard group, from 14:45 to 15:00.

Dr. Annu Heinonen, MD, PhD, serves as the Head of the Colposcopy Unit at Helsinki University Hospital, demonstrating her leadership and expertise in the field. Additionally, she holds positions as a board member of the Finnish Colposcopy Society and serves as the Secretary of the Nordic Colposcopy Society (Norcolp), contributing significantly to the advancement of colposcopy practices and research in Finland and across the Nordic region.

 

* Wednesday 18th of September 2024, Basic colposcopy course, Speaker of Colposcopic management and Interactive sandhands-on session, from 13:30 to 17:00.

* Saturday 21st of September 2024, Chair of Selected best oral presentations, from 08:30 to 10:15.

Dr. Christine Bergeron, President of CerbaPath in Paris, France, boasts an illustrious career at the forefront of women’s health. Her extensive leadership roles include Past President of the French Society of Colposcopy and Cervical Vaginal Pathology (SFCPCV), the European Federation of Colposcopy (EFC), and the French Society of Clinical Cytology (SFCC).

Christine is affiliated with numerous prestigious learned societies worldwide, focusing on cytopathology, colposcopy, gynaecology, vulvar disease, cervical cancer, and endometrial cancer. Actively engaged in Administrative and Scientific Bodies, she has authored over 100 international peer-reviewed papers, solidifying her reputation as a trailblazer in the field of women’s health research and practice.

 

* Thursday 19th of September 2024, Working towards eliminating cervical cancer: current knowledge on HPV natural history and screening: part II. Speaker of Do we need a co-testing? from 11:15 to 11:35.

* Saturday 21st of September 2024, Chair of Multidisciplinary team meetings in colposcopy, from 10:45 to 12:45.

Professor Dace Rezeberga, Head of the Department of Obstetrics and Gynaecology at Riga Stradins University, holds key positions in Latvia’s healthcare landscape. As Medical Director of Riga Maternity Hospital and Lead Specialist in Obstetrics and Gynaecology at the Ministry of Health of the Republic of Latvia, she drives advancements in maternal and reproductive healthcare. Her expertise extends to serving as Lead Specialist in Obstetrics and Gynaecology at Riga East Clinical University Hospital, furthering her impact on patient care and research. Professor Rezeberga’s primary research areas encompass genital tract infections, cervical cancer screening organisation, causes of preterm deliveries, labour induction, perinatal care organisation, and quality indicators of reproductive health, cementing her status as a leading authority in women’s health research and practice.

 

* Thursday 19th of September 2024, Chair of HPV vaccination: moving towards cervical cancer eradication, from 14:30-16:00.

Dr. Deidre Lyons serves as the Lead Clinician for Colposcopy at Imperial College Healthcare NHS Trust in London, where she is dedicated to advancing cervical healthcare. In addition to her clinical role, Deidre is the London Screening Quality Assurance Professional Clinical Advisor, ensuring the highest standards of screening quality across the region.

Dr. Deidre holds the esteemed position of President-Elect of BSCCP and is a member of the Advisory Board of EFC, contributing significantly to the advancement of colposcopy practices nationally and internationally. Deidre has played a crucial role as the BSCCP OSCE facilitator, leading the transition from face-to-face to online exams during the pandemic, showcasing her adaptability and commitment to educational excellence.

 

* Wednesday 18th of September 2024, Chair of Workshop – Difficult cases in colposcopy and Speaker of Glandular pathology cases, from 09:00 to 12:30.

* Wednesday 18th of September 2024, Chair of Workshop – Difficult cases in colposcopy and Speaker of Anal and multizonal disease Cases, from 13:30 to 17:00.

Dr. Eva Maria Niine, Oncogynaecologist Senior Physician at North Estonia Medical Centre, leads in women’s health care. She serves as a board member of both the Estonian Colposcopy Society and the Estonian Gynaecologists Society, driving advancements in cervical health care. Dr Eva is a vital member of the working group for the HPV-based National Cervical Cancer Screening Programme, contributing significantly to the improvement of cervical cancer prevention and detection in Estonia.

 

* Friday 20th of September 2024, Chair of Selected best oral presentations, from, 17:30 to 18:00.

* Saturday 21st of September 2024, Multidisciplinary team meetings in colposcopy, Speaker of Multidisciplinary team meeting in Colposcopy Case 2, from 11:15 to 11:35. 

Professor Evangelos Paraskevaidis, MD, PhD, is a distinguished figure at Ioannina Medical School, Greece, renowned for his expertise in Gynecological Oncology. As President of the Hellenic Society of Colposcopy and Cervical Pathology, and President of the Hellenic Cervical Pathology Academic Studies Group, he leads efforts to advance cervical health care and research in Greece. With clinical interests spanning all aspects of Gynecological Oncology, Professor Paraskevaidis specialises particularly in Colposcopy & Cervical Pathology. His prolific academic contributions include 180 articles on PubMed and 295 research items on ResearchGate, reflecting his substantial impact in the field. With an impressive h-index of 58 on Google Scholar and over 16,000 citations, Professor Paraskevaidis is recognised as a leading authority in Gynecological Oncology research.

 

* Friday 20th of September 2024, Ensuring the prevention of cervical cancer: reducing the risk for women post-treatment, Speaker of Reasons of recurrent and residual disease after cervical SIL treatment, from 16:00 to 16:15.

Dr. Gilbert Gerard Ghislain Donders, MD, PhD, is a distinguished obstetrician and gynaecologist with extensive clinical and research experience. He has held various academic and clinical positions, contributing significantly to women’s health. Dr. Donders is renowned for his expertise in infectious diseases in obstetrics and gynaecology and has conducted numerous research projects in the field. He is also actively involved in teaching and mentoring, furthering the knowledge and skills of future healthcare professionals. Additionally, Dr. Donders is a member of several prestigious scientific societies and serves on various editorial boards, demonstrating his commitment to advancing medical science.

 

* Thursday 19th of September 2024, Working towards eliminating cervical cancer:current knowledge on HPV natural history and screening: part II, Speaker of Self-testing of HPV in urine, from 12:05 to 12:15.

Dr. Grainne Flannelly is a long-time consultant obstetrician and gynaecologist, with over two decades of experience at the National Maternity Hospital in Dublin. Serving as lead colposcopist since 2002, she oversaw a high-volume service, attending to over 2500 new patients annually. Dr. Flannelly is deeply committed to medical education, leading digital learning initiatives at the BSCCP and NMH, and holds a clinical professorship at UCD School of Medicine. As former Clinical Director of CervicalCheck, she implemented quality improvement measures for colposcopy services nationwide and contributed to vital publications. Her research focuses on low-grade abnormalities and the utility of HPV testing in cervical screening, collaborating with Cerviva consortium. Dr. Flannelly’s expertise extends to IT applications in clinical settings, chairing committees both nationally and internationally, driving advancements in colposcopy training and online learning resources.

 

* Wednesday 18th of September 2024, Workshop – Difficult cases in colposcopy, Speaker of Glandular pathology Cases, from 11:00 to 12:30.

* Thursday 19th of September 2024, Chair of Communication with patients and social media and Speaker of New paradigm of social media, from 16:30 to 16:45. 

Dr. Ikka is a Consultant at Helsinki University Hospital, specializing in Obstetrics and Gynaecology. His expertise lies in the clinical epidemiology of cervical cancer prevention, colposcopy, and translational research on cervicovaginal microbiome and immune defense in HPV-related diseases. He actively contributes to the Finnish Current Care Guideline group on managing female anogenital HPV-related diseases and serves on the board of the Finnish Colposcopy Society. Dr. Ikka’s dedication to advancing women’s health underscores his commitment to research and clinical practice in gynaecological oncology.

 

* Saturday 21st of September 2024,Cervical pre/cancer and reproductive outcomes, Speaker of HPV infection and fertility, from 09:15 to 09:30.

Iryna Muryzina is an Associate Professor at Kharkiv National Medical University, Ukraine, specializing in Obstetrics and Gynaecology. With over two decades of experience as a gynaecologist, she has also established herself as a clinical researcher with 82 publications and a PhD. Dr. Muryzina has been actively involved in local studies addressing cervical screening failure, errors in HSIL recognition, and improving precision, as well as researching HPV infection in the context of bacterial vaginosis. She has contributed to understanding the challenges in colposcopists’ training in Ukraine and has played a crucial role in maintaining cervical screening amidst social turbulence. Dr. Muryzina’s dedication to women’s health has been recognized with the EFC-2022 Diakamanolis Prize.

 

* Saturday 21st of September 2024, Multidisciplinary team meetings in colposcopy, Speaker of Report of recipient of the Emmanuel Diakomanolis EFC Colposcopy prizes 2022:Experience on quality assurance system in UK, from 12:15 to 12:30.

Dr. Jana Žodžika, MD, PhD, leads as the Head of the Gynaecology Clinic at Riga East University Hospital and serves as an associate professor at Riga Stradiņš University. With expertise in colposcopy, cervical cancer prevention, reproductive tract infections, and gynaecologic surgery, she contributes significantly to women’s health. Dr. Žodžika plays a pivotal role as Secretary of the European Federation for Colposcopy and as a board member of the Latvian Association of Obstetricians and Gynaecologists, advancing standards and practices in her field at both national and international levels.

 

* Wednesday 18th of September 2024, Chair of Basic colposcopy course and  Speaker of Colposcopic principles, from 09:00 to 10:30;

* Wednesday 18th of September 2024, Chair of Basic colposcopy course and Speaker of Colposcopic diagnosis , from 11:00 to 12:30

* Wednesday 18th of September 2024, Chair of Basic colposcopy course and Speaker of Interactive sand hands-on session, from 15:30 to 17:00.

* Thursday 19th of September 2024, Chair of Working towards eliminating cervical cancer: current knowledge on HPV natural history and screening: part II, from 11:15 to 12:45.

Saturday 21st of September 2024, Chair of Selected best oral presentations, from 08:30 to 09:00.

Dr. Jean-Luc Mergui is a distinguished figure in Obstetrics & Gynaecology, specialising in Oncological Surgery. He holds the prestigious position of President of the International Federation for Cervical Pathology and Colposcopy (IFCPC), leading efforts in cervical health on a global scale. Dr. Mergui serves as the Medical School Director at Université Paris VI for the Colposcopic diploma, shaping the education of future healthcare professionals. With a wealth of experience, he has previously served as President of the French Colposcopic Society (SFCPCV), contributing significantly to advancements in colposcopy and cervical health in France.

 

* Friday 20th of September 2024, Challenges in colposcopy, Speaker of Management of women with type 3 TZ, from 11:00 to 11:15.

Johanna Verrikko, from Finland, navigates the realms of finance while pursuing studies in social sciences. Despite her challenges with high-risk HPV for over four years, leading to cervical cancer in spring 2023, Johanna remains resilient. Having undergone numerous colposcopies, she brings varied experiences of patient-doctor communication. Johanna is associated with the Gynecological Cancer Patients in Finland, a national advocacy organization providing reliable materials, counseling, and peer support for patients and their families. Her journey exemplifies strength and advocacy in the face of adversity.

 

* Thursday 19th of September 2024, Communication with patients and social media, Speaker of A patient voice, from 17:00 to 17:10. 

John Doorbar, Professor of Viral Pathogenesis at the University of Cambridge, brings a wealth of experience from his tenure at the National Institute for Medical Research in London. With a PhD in Cancer Studies from Birmingham and a first degree in Genetics & Microbiology from the University of Leeds, he specializes in understanding the organization of the human papillomavirus (HPV) life cycle. Throughout his career, Professor Doorbar has focused on elucidating how interactions between HPV and infected epithelial cells contribute to neoplasia and cancer development. His current research delves into lesion formation and regression mechanisms, as well as how HPV modulates epithelial homeostasis to persist. His group’s work centres on the cervical transformation zone, unraveling the molecular and cellular processes underlying HPV infection and neoplastic progression in this critical epithelial site.

 

* Thursday 19th of September 2024, Current knowledge on HPV natural history, Speaker of Current evidence for HPV natural history and latency, from 09:15 to 09:30.

Dr. Karoliina Aro MD, PhD, is a specialist in Obstetrics and Gynecology and gynecologic oncologist working at Helsinki University Hospital.

 

* Friday 20th of September 2024,Optimal management of cervical intraepithelial lesions, Speaker of Clinical management of CIN2 across countries, from 09:15 to 09:30.

Dr. Karolina Louvanto, MD, PhD is Professor (tenure track) and Deputy Chief in Obstetrics and Gynecology at the Faculty of Medicine and Health Technology, Tampere University and Tampere University hospital, Finland. With a broad expertise in molecular epidemiology and biomarkers related to human Papillomavirus (HPV) infection and disease progression, Dr. Louvanto’s research focuses on establishing optimal cervical cancer screening tools and guidelines for both unvaccinated and HPV-vaccinated women. Her dedication to advancing women’s health through cutting-edge research makes her a leader in the field.

 

* Friday 20th of September 2024,Optimal management of cervical intraepithelial lesions, Speaker of Risk stratifications of CIN2 for clinical management, from 09:45 to 10:00.

Dr. Kathrine Dyhr Lycke, MD, is a dedicated postdoctoral researcher at the Department of Obstetrics and Gynecology, Gødstrup Hospital, Denmark. A graduate of Aarhus University in 2016, she embarked on her journey in obstetrics and gynecology training in 2018. In 2023, Dr. Lycke successfully defended her PhD dissertation focusing on CIN2 and associated risks under active surveillance. Her contributions to the field highlight her commitment to advancing knowledge in women’s health and cervical cancer prevention.

 

* Friday 20th of September 2024, Optimal management of cervical intraepithelial lesions, Speaker of Risk associated with active surveillance for CIN2, from 09:30 to 09:45. 

Dr. Kristina Jarienè, MD, PhD, is a Professor at Lithuanian University of Health Sciences and an Obstetrician Gynecologist at Kauno Klinikos. With 24 years of clinical experience, her focus areas include gynaecological endocrinology, infertility, and perinatal care. Dr. Jarienè actively contributes to academia as a scientific journal editor and member of various boards and committees, including the European Federation of Colposcopy and the FIGO Committee on Women Facing Crises. She leads postgraduate courses, mentors medical professionals, and contributes to projects aimed at improving oncological screening programs and protocols for sexually abused individuals in EU countries.

 

* Friday 20th of September 2024, Chair of Selected best oral presentations from 08:30 to 09:00 

* Friday 20th of September 2024, Chair of Challenges in colposcopy from 11:15 to 12:45.

* Saturday 21st of September 2024, Multidisciplinary team meetings in colposcopy, Speaker of Multidisciplinary team meeting in Colposcopy Case 1, from 10:55 to 11:15. 

Dr. Laura Kotaniemi-Talonen, MD, PhD, is a gynecologist and certified colposcopist in Finland. With a background in Obstetrics and Gynecology from Tampere University, she serves as Deputy Chief in the Department of Obstetrics and Gynecology at The Wellbeing Services County of Pirkanmaa. Leading the colposcopy services at Tampere University Hospital, she began her research career focusing on cervical cancer screening and continues this work as an Associate Professor at Tampere University. Dr. Kotaniemi-Talonen is the president of the Finnish Society for Colposcopy and leads the Finnish Current Care Guidelines group, contributing to national recommendations for cervical, vaginal, and vulvar lesion treatment. Additionally, she actively participates in the EFC Quality and Standards Group.

 

* Thursday 19th of September 2024, Chair of Current knowledge on HPV natural history, from 09:15 to 10:45 

* Thursday 19th of September 2024, Communication with patients and social media, Speaker of How to inform patients and which information should we provide about HPV infection and vaccination, from 16:45 to 17:00.

Luka Roškar, MD, PhD, leads the Gynecology and Obstetrics Department at General Hospital Murska Sobota, Slovenia. Recognized for his clinical research on endometrial cancer biomarkers, he earned the International Medis Award in 2021 and the Diakomanolis Prize from EFC in 2022. He contributes actively to the Slovenian Cervical Cancer Screening Program (ZORA) and the Slovenian Colposcopic Society.

 

* Saturday 21st of September, Multidisciplinary team meetings in colposcopy, Speaker of Report of recipient of the Emmanuel Diakomanolis EFC Colposcopy prizes 2022:Experience on training and education programme in colposcopy in Finland, from 12:30 to 12:45. 

Dr. Maciej Mazurec, MD, is a gynaecologist-obstetrician and PSCCP-certified Master of Colposcopy. He serves as the Executive Secretary of the PSCCP and is the CEO and Founder of Corfamed Woman’s Health Center in Wroclaw. Dr Mazurec’s clinical practice and research focus on liquid-based cervical cancer screening within HPV-related strategies, and standardising colposcopy procedures. He also holds the position of Secretary in the Executive Committee of the Colposcopy 2020 Project, aiming to enhance Polish colposcopy practice standards, from pre-colposcopic procedures to post-colposcopic management of cervical biopsy results.

 

* Thursday 19th of September 2024,Working towards eliminating cervical cancer:current knowledge on HPV natural history and screening: part II,  Speaker of Is high-grade squamous intraepithelial lesion risk-based management the future of cervical cancer screening? from 11:35 to 11:45. 

Professor Maggie Cruickshank, MB ChB MD FRCOG, holds the position of Emeritus Professor/Clinical Consultant of Gynaecology at the Aberdeen Centre for Women’s Health Research (ACWHR), affiliated with the University of Aberdeen and NHS Grampian in the UK. She serves as President of the European Federation of Colposcopy (EFC) and has previously served as President of the British Society of Colposcopy and Cervical Pathology (BSCCP). Additionally, she chairs the IFCPC training and education committee.

 

* Wednesday 18th of September 2024, Workshop – Difficult cases in colposcopy, Speaker of Anal and multizonal disease cases, from 15:30 to 17:00.

* Thursday 19th of September 2024, Chair of Working towards eliminating cervical cancer: current knowledge on HPV natural history and screening: part II, from 11:15 to 12:45 

* Thursday 19th of September 2024, HPV vaccination: moving towards cervical cancer eradication, Speaker of Impact of vaccination on colposcopy from 14:55 to 15:10.

* Friday 20th of September 2024, Chair of Ensuring standards and quality assurance in women in Europe: colposcopy standards and Speaker of Challenging colposcopy cases: applying EFC/ESGO European consensus statement on expert colposcopy, from 14:00 to 14:15.

Dr. Maggiorino Barbero is a distinguished Medical Doctor with specialisations in Gynaecology and Oncology. Currently, he serves as the Chief of the Department of Obstetrics and Gynecology at ASL AT in Italy. Additionally, he holds the esteemed position of Adjunct Professor of Gynecology at the University of Turin. Dr. Barbero’s significant contributions extend to his role as President of the Italian Society of Colposcopy (SICPCV) from 2015 to 2023, followed by his current position as Immediate Past President. He is widely regarded as an expert in LLETZ procedures for preneoplastic cervico-vaginal lesions.

* Friday 20th of September 2024, Ensuring the prevention of cervical cancer: reducing the risk for women post-treatment, Speaker of Post-treatment follow-up of cervical SIL and adenocarcinoma in situ, from 16:30 to 16:45.

Dr. Marc Arbyn is the Coordinator of the Unit of Cancer Epidemiology at the Belgian Cancer Centre, Sciensano. With a background in Médecins Sans Frontières, he’s now a leading figure in European cancer research. Specialising in HPV-related cancers, he’s authored hundreds of papers and is involved in international networks for cancer research and prevention. He leads studies like VALGENT and VALHUDES, advancing HPV testing methods and validation.

 

* Thursday 19th of September 2024, Current knowledge on HPV natural history, Speaker of Triage of HPV-positive patients, from 10:00 to 10:15 

* Thursday 19th of September 2024, HPV vaccination: moving towards cervical cancer eradication, Speaker of Status of HPV vaccination in Europe – results of EU4Joint Action PERCH, from 14:30 to 14:40. 

Professor Maria Kyrgiou, Consultant Gynaecologic Oncology Surgeon at Imperial College London, is renowned for her translational research in gynaecological diseases and cancers, focusing on prevention and early detection. She leads the NOVEL trial, evaluating HPV vaccination post-cervical pre-invasive disease treatment. With extensive publications, she chairs the BSCCP Research Committee and contributes to international committees like the ESGO Prevention Committee.

 

* Saturday 21st of September 2024, Chair of Cervical pre/cancer and reproductive outcomes and Speaker of Optimal decision making in management of SIL from 09:00 to 10:15. 

PD Dr. Melanie Henes serves as the Head Senior Physician at the Dysplasia Unit and the Hormone and Fertility Clinic within the Department of Women’s Health at the University of Tuebingen, Germany. She also holds the position of Chair of the Board of the Association for Cervical Pathology and Colposcopy e.V. of Germany. Her expertise and leadership contribute significantly to advancing women’s health care and research in Germany.

 

* Saturday 21st of September 2024, Multidisciplinary team meetings in colposcopy, Speaker of Multidisciplinary team meeting in colposcopy Case 3 from 11:35 to 11:55.

 

Dr. Mihaela Grigore, Ph.D., is a Professor of Obstetrics and Gynecology at “Grigore T. Popa” University of Medicine and Pharmacy, Iasi, Romania. Specializing in cervical, vaginal, and vulvar pathology, she serves as Secretary of the “Romanian Society of Colposcopy and Inferior Genital Tract Pathology”. Dr. Grigore is dedicated to enhancing cervical cancer screening and has authored numerous papers on the subject. With a keen interest in medical education, she has organized workshops and courses on colposcopy and cervical cancer, including sessions endorsed by the European Federation of Colposcopy.

 

* Wednesday 18th of September, Workshop – Difficult cases in colposcopy, Speaker of Pregnancy cases from 09:00 to 10:30. 

* Saturday 21st of September, Chair of Cervical pre/cancer and reproductive outcomes from 09:00 to 10:15.

Dr. Elfström, an epidemiologist at the Center for Cervical Cancer Elimination, Karolinska University Hospital, Sweden, leads the Swedish National Working Group for Cervical Cancer Prevention. She spearheads efforts in monitoring, evaluating, and enhancing screening programs, with a recent focus on HPV self-sampling and risk-stratified screening. Chairing the International Cancer Screening Network, she collaborates on evidence-based global cancer screening initiatives. Her research aims to optimize prevention strategies, including health system strengthening and program quality assurance.

 

* Friday 20th of September 2024, Ensuring standards and quality assurance in women in Europe: colposcopy standards, Speaker of Cervical cancer screening in Europe: quality assurance and organisation of programmes in 2024 from 14:15 to 15:00. 

Dr. Natalya serves as the president of the Ukrainian Association of Colposcopy and Cervical Pathology (UACCP) since 2017, As a gynecological oncologist and professor leading the department of oncology and medical radiology at Danylo Halytsky Lviv National Medical University. Her presidency focuses on organising cervical cancer prevention efforts, advocating for HPV vaccination and cervical screening, organising colposcopy courses, and integrating European practices while considering Ukraine’s economic and demographic context.

 

* Friday 20th of September 2024, Challenges in colposcopy, Speaker of Prospects of eliminating cervical cancer in Ukraine from 12:00 to 12:15. 

Dr. Olaf Reich, an Associate Professor of Gynaecology and Pathology at the Medical University of Graz, Austria, holds esteemed positions within the field. He serves as President of the Austrian Society for Colposcopy, a Fellow of ISSVD, and a member of the EFCPC Nomenclature Committee. Dr. Reich is renowned for his expertise in Uterine Cervical Diseases, Colposcopy, and Vulvar Diseases, making significant contributions to the advancement of these areas.

 

* Thursday 19th of September 2024, Working towards eliminating cervical cancer:current knowledge on HPV natural history and screening: part II, Speaker of Do we need a co-testing? from 11:15 to 11:35. 

Dr. Olga Plisko, MD, is a distinguished gynecologist and colposcopy specialist at Riga East University Hospital. Additionally, she serves as an assistant at the Department of Obstetrics and Gynaecology at Riga Stradins University. Dr. Plisko holds the esteemed position of Head of the Latvian Colposcopy Society, where she contributes significantly to the advancement of colposcopy practices and research in Latvia.

 

* Thursday 19th of September 2024, Current knowledge on HPV natural history, Speaker of The role of microbiome on HPV infection and SIL from 09:45 to 10:00

* Thursday 19th of September 2024, Chair of Session of best selected oral presentations nominated for U. Petry price for the junior scientists from 17:30 to 18:30.

Dr. Pekka Nieminen, MD, PhD, is an esteemed Associate Professor at the University of Helsinki. Formerly serving as President of the European Federation for Colposcopy (EFC), he is a renowned expert in colposcopy, cervical cancer prevention, HPV vaccines, and screening. With over 230 peer-reviewed articles, Dr. Nieminen is a prolific researcher dedicated to advancing women’s health. Beyond academia, he enjoys sailing, cycling, alpine skiing, and cherishes time with his grandchildren.

 

* Thursday 19th of September 2024, Chair of HPV vaccination: moving towards cervical cancer eradication and Speaker of Novel study-preliminary results from 14:30 to 16:00.

* Saturday 21st of September 2024, Chair of Multidisciplinary team meetings in colposcopy and Speaker of How to organise an MDT in colposcopy clinic, from 10:45 to 12:45.

Professor Robert Jach, MD, PhD, is a distinguished obstetrician-gynecologist, gynecological oncologist, and expert in gynecological endocrinology and reproduction. With extensive training at prestigious institutions like Columbia University and Memorial Sloan Kettering Cancer Center in New York, he brings a wealth of knowledge to his role as Head of the Department of Gynecological Endocrinology and Gynecology at Jagiellonian University Medical College and University Hospital in Krakow. Prof. Jach is a prolific author with 259 scientific papers and has supervised 7 doctoral theses. As President of the Polish Society of Colposcopy and Pathophysiology of the Cervix, Vice President of the Polish Society of Gynecologists and Obstetricians, and a member of several international boards, including the EFC and IFCPC, Prof. Jach is dedicated to advancing women’s health on a global scale.

 

* Friday 20th of September 2024, Chair of Ensuring standards and quality assurance in women in Europe: colposcopy standards from 14:00 to 15:30.

* Saturday 21st of September 2024, Cervical pre/cancer and reproductive outcomes, Speaker of Fertility sparing treatment in cervical cancer – selection of candidates and management ESGO/ESTRO/ESP Update 2023, from 09:00 to 09:15.

Dr. Robert Koiss, MD, Ph.D., is a renowned gynecological oncologist with a distinguished career spanning over two decades. After graduating from Semmelweis University in Hungary in 1996, he obtained specialist exams in obstetrics and gynecology in 2003 and clinical oncology in 2005. Dr. Koiss has been an integral member of the Advisory Board of the Hungarian Cancer Prevention Committee since 2008, contributing his expertise to advance cancer prevention initiatives. From 2013 to 2015, he served as the professional manager of a project aimed at expanding cervical screening by midwives within Hungary. Since 2016, Dr. Koiss has been a dedicated board member of the Hungarian Gynecology-Oncology Society and notably served as the president of the Hungarian Cervical and Colposcopy Society from 2016 to 2022, furthering the cause of women’s health in his country.

 

* Friday 20th of September 2024, Ensuring standards and quality assurance in women in Europe: colposcopy standards, Speaker of Ambitions for quality assurance in Hungary from 14:30 to 14:45.  

Prof. Dr. Ruud Bekkers is a distinguished gynecologic oncologist with extensive training and expertise in cervical (pre)malignancies. His career began in the Netherlands, where he completed his gynecology fellowship and wrote a PhD on HPV’s role in managing patients with CIN. Passionate about advancing women’s health, he has authored over 100 papers and numerous book chapters on cervical abnormalities. Prof. Bekkers’ interest in cervical cancer was sparked during his time as a tropical doctor in South Africa, where he witnessed the impact of limited screening on HIV-positive women. He later pursued a fellowship in gynecologic oncology and served as a gynecologic oncologist at the Radboud University Medical Center. Prof. Bekkers specializes in minimal invasive surgery and cervical cancer prevention and treatment. He has held leadership roles, including chair of the Dutch colposcopy society and director of O&G training. Currently, he heads the gynaecologic oncology unit at the Catharina Hospital Eindhoven and holds a professorship at Maastricht University, focusing on HPV vaccination, screening, and the microenvironment of CIN lesions.

 

* Friday 20th of September 2024, Challenges in colposcopy, Speaker of Screening and management of immunocompromised women from 11:45 to 12:00. 

Dr. Simopekka Vänskä, PhD in Mathematics since 2007, serves as an Associate Professor in Applied Mathematics at the University of Helsinki. As a Senior Researcher at the Finnish Institute for Health and Welfare (THL), he employs mathematical modelling to inform national decision-making on infectious diseases and vaccination strategies. His expertise spans HPV-related issues, encompassing transmission dynamics, vaccination policies, and strategies for cervical cancer screening and other HPV-related cancers.

 

* Thursday 19th of September 2024, HPV vaccination: moving towards cervical cancer eradication, Speaker of Impact of vaccination on screening from 14:40 to 16:55.

Dr. Tamar Alibegashvili, MD, PhD, heads the Gynecological Department at the Georgian National Screening Center in Tbilisi. With expertise in colposcopy, cervical cancer prevention, and conservative gynecology, she plays pivotal roles in academia and professional organizations. Tamar chaired the development of Georgian guidelines for cervical cancer prevention in 2010 and 2022, and she spearheaded the creation of the Georgian colposcopy training program. With over 15 years of teaching experience, she is committed to advancing medical education. Additionally, Tamar serves as President of the Georgian Society for Cervical Pathology and Colposcopy, and she is a Trustee of the European Federation for Colposcopy. As an Obstetrician-Gynaecologist and Colposcopy Specialist, she contributes extensively to the field of women’s health in Georgia.

 

* Friday 20th of September 2024, Chair of Selected best oral presentations from 17:30 to 18:00.  

Dr. Vesna Kesić, PhD, is a distinguished professor at the Faculty of Medicine, University of Belgrade. With over 30 years of experience as a specialist in Obstetrics and Gynecology, she holds sub-specialization in oncology and is recognized as a gynecologic oncologist by ESGO. Dr. Kesić is renowned for her expertise in colposcopy, with nearly four decades of practice. She is the founder of the Yugoslav Society for Colposcopy and played a pivotal role in its establishment as one of the original member countries of EFC. Additionally, she organized the EFC congress in Belgrade in 2004. Serving as the president of the Serbian Society for Colposcopy from 2012 to 2023, Dr. Kesić has made significant contributions to the field. She also held the esteemed position of President of ESGO from 2013 to 2015. Dr. Kesić is the recipient of numerous prestigious awards, recognising her outstanding contributions to gynecologic oncology and colposcopy.

 

* Wednesday 18th of September 2024, Chair of Workshop – Difficult cases in colposcopy and Speaker of VIN& VaIN Cases from 13:30 to 15:00.

* Friday 20th of September 2024, Ensuring the prevention of cervical cancer: reducing the risk for women post-treatment, Speaker of Follow up after VIN and VaIN treatment from 16:45 to 17:00. 

Dr. Wojciech Kolawa, MD, PhD, is a distinguished gynecologist and oncologist affiliated with Narutowicz Specialist Hospital in Krakow, Poland, where he serves as the Head of the Department of Obstetrics, Gynecology, and Oncology. He is also the Secretary of the Polish Society for Colposcopy and Cervical Pathophysiology. With his expertise in gynecology and oncology, Dr. Kolawa plays a crucial role in advancing the field of women’s health and cancer prevention in Poland.

 

* Friday 20th of September 2024, Challenges in colposcopy, Speaker of Colposcopy of pregnant women from 11:30 to 11:45. 

Professor Xavier Carcopino, MD, PhD, leads the department of gynecologic surgery at Hôpital Nord in Marseille, France. Specialising in colposcopy, cervical cancer prevention, gynecologic surgery, and oncology, he serves as a Professor at Aix Marseille University. With over 150 referenced articles and three books to his credit, Professor Carcopino is a prominent figure in the field. He holds key leadership roles as President of the European Federation for Colposcopy (EFC) and the French Society of Colposcopy (SFCPCV).

 

* Wednesday 18th of September 2024,Workshop – Difficult cases in colposcopy, Speaker of VIN& VaIN Cases from 13:30 to 15:00.

* Friday 20th of September 2024, Optimal management of cervical intraepithelial lesions, Speaker of Optimal treatment strategies of adenocarcinoma in situ from 10:00 to 10:15,

* Friday 20th of September 2024, Chair of Challenges in colposcopy from 11:15-12:45

* Friday 20th of September 2024, Chair of Ensuring the prevention of cervical cancer: reducing the risk for women post-treatment from 16:00 to 17:30.